We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others ...

Intech Investment Management LLC acquired a new stake in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and ...

Charles Schwab Investment Management Inc. raised its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

Bristol-Myers Squibb awarded its CEO nearly $19 million in compensation for 2024, following a challenging year for the ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Harrow, Inc. offers speculative gains from $20s to $30s, with Q4 growth, bullish 2025 revenue guidance, and long-term growth ...

Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 61.33%, which has investors questioning if this is right time to buy.

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Learn more about Ascentage Pharma Group International's (AAPG) stock grades for Value and Growth and determine whether this Biotechnology stock meets your investment needs.